Altimmune Inc (NAS:ALT)
$ 7.33 -0.06 (-0.81%) Market Cap: 519.71 Mil Enterprise Value: 342.50 Mil PE Ratio: 0 PB Ratio: 3.00 GF Score: 30/100

Altimmune Inc at JMP Securities Life Sciences Conference Transcript

Jun 16, 2022 / 01:00PM GMT
Release Date Price: $7.34 (-11.78%)
Jon Wolleben
JMP Securities LLC - Analyst

Thanks for coming out on a wet morning. My name is Jon Wolleben, senior analyst here at JMP Securities. And Altimmune is a company we have been covering for quite some time that's seeing a lot of excitement in the obesity space. So we are pleased to have CEO, Vipin Garg; and Chief Medical Officer, Scott Harris joining us today. Thanks for making it out today, guys.

Scott Harris
Altimmune, Inc. - Chief Medical Officer

Sure.

Vipin Garg
Altimmune, Inc. - President & CEO

Yes, absolutely. Our pleasure. Thank you for inviting us.

Questions & Answers

Jon Wolleben
JMP Securities LLC - Analyst

And maybe, Vipin, to start, some people may not be as familiar with Altimmune. Can you give a little bit about the history of the company and your focus today?

Vipin Garg
Altimmune, Inc. - President & CEO

Yeah, sure. So as you mentioned, we are working in the obesity space. We have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot